Sintx Technologies (SINT) Net Income towards Common Stockholders Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39% |
| Dec 31, 2025 | -19.13% |
| Sep 30, 2025 | -32.50% |
| Jun 30, 2025 | 10.46% |
| Mar 31, 2025 | 5.19% |
| Dec 31, 2024 | -1.35% |
| Sep 30, 2024 | -26.38% |
| Jun 30, 2024 | 7.52% |
| Mar 31, 2024 | -18.03% |
| Dec 31, 2023 | -48.59% |
| Sep 30, 2023 | 24.11% |
| Jun 30, 2023 | -9.57% |
| Mar 31, 2023 | -3.61% |
| Dec 31, 2022 | -35.54% |
| Sep 30, 2022 | -5.65% |
| Jun 30, 2022 | -9.00% |
| Mar 31, 2022 | -40.92% |
| Dec 31, 2021 | -20.28% |
| Sep 30, 2021 | 27.21% |
| Jun 30, 2021 | 15.37% |
| Mar 31, 2021 | 4.92% |
| Dec 31, 2020 | 33.54% |
| Sep 30, 2020 | 24.34% |
| Jun 30, 2020 | 7.45% |
| Mar 31, 2020 | 11.05% |
| Dec 31, 2019 | 30.39% |
| Sep 30, 2019 | 17.07% |
| Jun 30, 2019 | 22.42% |
| Mar 31, 2019 | 19.14% |
| Dec 31, 2018 | -29.15% |
| Sep 30, 2018 | -43.09% |
| Jun 30, 2018 | 6.58% |
| Mar 31, 2018 | -1.04% |